Ann Arbor, United States
Arboretum Ventures seeks to invest in nascent life sciences companies and operates as a venture capital firm. Their investment targets include medical devices and diagnostics, biotechnology and pharmaceuticals, and health care services. This firm often serves as a founder's initial professional investor and frequently provides seed and early-stage investments. Arboretum remains committed to the success of their portfolio companies by maintaining a hands-on approach with their investments.
76
Total Investments
44
Portfolio Companies
-
Exits
-
Industries
General Information
Funding Stage
Pre Seed +4
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Arboretum Ventures
Recent Investments (76)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Late Vc | •••••• | Jun 2025 | |
| Series C | •••••• | Jan 2025 | |
| Venture Round | •••••• | Jun 2024 | |
| Series C | •••••• | Apr 2024 | |
| Series C | •••••• | Apr 2024 | |
•••• ••••
|
Series C | •••••• | Mar 2024 |
|
•••• ••••
|
Series A | •••••• | Feb 2024 |
|
•••• ••••
|
Series C | •••••• | Feb 2024 |
|
•••• ••••
|
Series A | •••••• | Jan 2024 |
|
•••• ••••
|
Series C | •••••• | Sep 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
